Cleocin T

Product NDC: 0009-3116
11-digit product format: 000093116
Labeler code: 0009
Product ID: 0009-3116_a5273475-0e0d-437f-a074-a770aea6d302
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: clindamycin phosphate
Dosage form: SOLUTION
Route: TOPICAL
Labeler: Pharmacia & Upjohn Company LLC
Application: NDA050537
Marketing category: NDA
Marketing start: 1980-06-20
Marketing end: 0000-00-00
Substance: CLINDAMYCIN PHOSPHATE
Active strength: 10 mg/mL
Pharmacologic classes: Decreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [CS],Neuromuscular Blockade [PE]
NDC exclude flag: No
Listing certified through: 2022-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 4 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	0009-3116		D	Discontinued by firm	2026-10-05
excluded package	package	0009-3116	0009-3116-01	D	Discontinued by firm	2026-10-05
excluded package	package	0009-3116	0009-3116-02	D	Discontinued by firm	2026-10-05
excluded package	package	0009-3116	0009-3116-14	D	Discontinued by firm	2026-10-05

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 48 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	0009-3116-01	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	0009-3116-02	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	0009-3116-14	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	0009-3116-01	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	0009-3116-02	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	0009-3116-14	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	0009-3116-01	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	0009-3116-02	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	0009-3116-14	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	0009-3116-01	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	0009-3116-02	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	0009-3116-14	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	0009-3116-01	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	0009-3116-02	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	0009-3116-14	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	0009-3116-01	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	0009-3116-02	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	0009-3116-14	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	0009-3116-01	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	0009-3116-02	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	0009-3116-14	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	0009-3116-01	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	0009-3116-02	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	0009-3116-14	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	0009-3116-01	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	0009-3116-02	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	0009-3116-14	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	0009-3116-01	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	0009-3116-02	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	0009-3116-14	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	0009-3116-01	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	0009-3116-02	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	0009-3116-14	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	0009-3116-01	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	0009-3116-02	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	0009-3116-14	`557ba5c1ecfa…`	`9c80585c8c6e…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N050537-001	CLEOCIN T	CLINDAMYCIN PHOSPHATE	EQ 1% BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	SOLUTION / TOPICAL		RLD, Approved before 1982
N050537-002	CLEOCIN	CLINDAMYCIN PHOSPHATE	EQ 1% BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	SWAB / TOPICAL		RLD	1994-02-22

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 86 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	N050537-001	CLEOCIN T	EQ 1% BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	SOLUTION / TOPICAL		RLD, Approved before 1982		`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N050537-002	CLEOCIN	EQ 1% BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	SWAB / TOPICAL		RLD	1994-02-22	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N050537-001	CLEOCIN T	EQ 1% BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	SOLUTION / TOPICAL		RLD, Approved before 1982		`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N050537-002	CLEOCIN	EQ 1% BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	SWAB / TOPICAL		RLD	1994-02-22	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N050537-001	CLEOCIN T	EQ 1% BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	SOLUTION / TOPICAL		RLD, Approved before 1982		`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N050537-002	CLEOCIN	EQ 1% BASE	SWAB / TOPICAL		RLD	1994-02-22	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N050537-001	CLEOCIN T	EQ 1% BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	SOLUTION / TOPICAL		RLD, Approved before 1982		`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N050537-002	CLEOCIN	EQ 1% BASE	SWAB / TOPICAL		RLD	1994-02-22	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N050537-001	CLEOCIN T	EQ 1% BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	SOLUTION / TOPICAL		RLD, Approved before 1982		`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N050537-002	CLEOCIN	EQ 1% BASE	SWAB / TOPICAL		RLD	1994-02-22	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N050537-001	CLEOCIN T	EQ 1% BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	SOLUTION / TOPICAL		RLD, Approved before 1982		`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N050537-002	CLEOCIN	EQ 1% BASE	SWAB / TOPICAL		RLD	1994-02-22	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N050537-001	CLEOCIN T	EQ 1% BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	SOLUTION / TOPICAL		RLD, Approved before 1982		`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N050537-002	CLEOCIN	EQ 1% BASE	SWAB / TOPICAL		RLD	1994-02-22	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N050537-001	CLEOCIN T	EQ 1% BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	SOLUTION / TOPICAL		RLD, Approved before 1982		`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N050537-002	CLEOCIN	EQ 1% BASE	SWAB / TOPICAL		RLD	1994-02-22	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N050537-001	CLEOCIN T	EQ 1% BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	SOLUTION / TOPICAL		RLD, Approved before 1982		`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N050537-002	CLEOCIN	EQ 1% BASE	SWAB / TOPICAL		RLD	1994-02-22	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N050537-001	CLEOCIN T	EQ 1% BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	SOLUTION / TOPICAL		RLD, Approved before 1982		`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N050537-002	CLEOCIN	EQ 1% BASE	SWAB / TOPICAL		RLD	1994-02-22	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N050537-001	CLEOCIN T	EQ 1% BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	SOLUTION / TOPICAL		RLD, Approved before 1982		`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N050537-002	CLEOCIN	EQ 1% BASE	SWAB / TOPICAL		RLD	1994-02-22	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N050537-001	CLEOCIN T	EQ 1% BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	SOLUTION / TOPICAL		RLD, Approved before 1982		`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N050537-002	CLEOCIN	EQ 1% BASE	SWAB / TOPICAL		RLD	1994-02-22	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N050537-001	CLEOCIN T	EQ 1% BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	SOLUTION / TOPICAL		RLD, Approved before 1982		`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N050537-002	CLEOCIN	EQ 1% BASE	SWAB / TOPICAL		RLD	1994-02-22	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N050537-001	CLEOCIN T	EQ 1% BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	SOLUTION / TOPICAL		RLD, Approved before 1982		`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N050537-002	CLEOCIN	EQ 1% BASE	SWAB / TOPICAL		RLD	1994-02-22	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N050537-001	CLEOCIN T	EQ 1% BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	SOLUTION / TOPICAL		RLD, Approved before 1982		`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N050537-002	CLEOCIN	EQ 1% BASE	SWAB / TOPICAL		RLD	1994-02-22	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N050537-001	CLEOCIN T	EQ 1% BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	SOLUTION / TOPICAL		RLD, Approved before 1982		`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	N050537-002	CLEOCIN	EQ 1% BASE	SWAB / TOPICAL		RLD	1994-02-22	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N050537-001	CLEOCIN T	EQ 1% BASE	SOLUTION / TOPICAL		RLD, Approved before 1982		`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N050537-002	CLEOCIN	EQ 1% BASE	SWAB / TOPICAL		RLD	1994-02-22	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N050537-001	CLEOCIN T	EQ 1% BASE	SOLUTION / TOPICAL		RLD, Approved before 1982		`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	N050537-002	CLEOCIN	EQ 1% BASE	SWAB / TOPICAL		RLD	1994-02-22	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N050537-001	CLEOCIN T	EQ 1% BASE	SOLUTION / TOPICAL		RLD, Approved before 1982		`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	N050537-002	CLEOCIN	EQ 1% BASE	SWAB / TOPICAL		RLD	1994-02-22	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N050537-001	CLEOCIN T	EQ 1% BASE	SOLUTION / TOPICAL	AT	RLD, RS, Approved before 1982		`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N050537-002	CLEOCIN	EQ 1% BASE	SWAB / TOPICAL	AT	RLD	1994-02-22	`74a2ff9319b5…`

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2019-12-13 00:20 UTC	2019-12	N050537-001	AT	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N050537-002	AT	1	`74a2ff9319b5…`
2021-03-12 10:30 UTC	2021-03	N050537-002	AT	1	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N050537-001	AT	1	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	N050537-002	AT	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N050537-001	AT	1	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	N050537-002	AT	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N050537-001	AT	1	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N050537-002	AT	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N050537-001	AT	1	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	N050537-002	AT	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N050537-001	AT	1	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	N050537-002	AT	1	`ea99ee380514…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
a46239a7-5963-4008-8cbb-6b9000f497eb	Product name	1	20250721
1426d8f8-b7d5-4053-8554-613df00c0d86	Product name	2	20250616
b382b4e1-6b48-45f6-bffc-e61b00b0ce19	Product name	3	20250317
d8f81258-db12-0761-46cc-8ff6e62e9302	Product name	4	20240422
b7b2fa42-1c77-d724-81f0-87da60a77e79	Product name	3	20240320
6c13b22c-b3ba-4127-b768-0132dd5ab0d1	Product name	1	20230829
b27c7c65-51f2-a62f-e0e6-a26b3a0f8eb0	Product name	3	20230425
e3af9708-3004-7392-4046-5311eaa8bab5	Product name	3	20221128
ffb4bacf-f636-0f7d-0b0d-7a4b151243e3	Product name	9	20220928
b72227d6-0388-43bd-995b-b762d2754cd5	Product name	1	20220706
a92d22e0-3af4-f301-bc88-27ff030b0070	Product name	2	20220316
4a7d44fe-774d-404b-aad0-8a90fe78375a	Product name	4	20211025
d12e2d7c-bd6b-45d4-94f9-6df8e1b8b27b	Product name	3	20200203
ee5c6de5-d9cd-454f-b250-7b19e5cf2992	Product name	4	20190619
5ce6ce33-4f2b-3ce0-757d-e520013280cf	Product name	5	20180719
b92a26f1-6926-4817-be73-e26ab4c2146f	Product name	1	20170602
028d6c95-5012-6976-2075-dee0ae6fefe2	Product name	1	20140508
468b2c08-8adb-8d0f-8257-c6515a061424	Product name	1	20140508
8959fb29-d86f-c521-666a-b4cb22233594	Product name	1	20140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
0009-3116-01	Cleocin T	30 mL in 1 BOTTLE	SOLUTION	30	30
0009-3116-01	Cleocin T	1 in 1 CARTON	SOLUTION	1	30
0009-3116-02	Cleocin T	60 mL in 1 BOTTLE	SOLUTION	60	30
0009-3116-02	Cleocin T	1 in 1 CARTON	SOLUTION	1	30
0009-3116-14	Cleocin T	1 mL in 1 PACKET	SOLUTION	1	30
0009-3116-14	Cleocin T	60 in 1 CARTON	SOLUTION	60	30

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
0009-3116-01	ML - Milliliter	0009-3116	1eb9d45c-b035-4158-88b9-76f48fe60f79	1	2012-07-24
0009-3116-02	ML - Milliliter	0009-3116	24f4dfd7-2c75-4f7f-b3eb-0239fd137bb6	1	2012-07-24
0009-3116-14	EA - Each	0009-3116	a906d567-2f88-4453-bc5c-6ea023f86daf	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
CLINDAMYCIN PHOSPHATE	ACTIVE INGREDIENT	EH6D7113I8	CLEOCIN T (CLINDAMYCIN PHOSPHATE) SOLUTION CLEOCIN T (CLINDAMYCIN PHOSPHATE) LOTION CLEOCIN T (CLINDAMYCIN PHOSPHATE) GEL [PHARMACIA AND UPJOHN COMPANY]	13
CLINDAMYCIN	ACTIVE MOIETY	3U02EL437C	CLEOCIN T (CLINDAMYCIN PHOSPHATE) SOLUTION CLEOCIN T (CLINDAMYCIN PHOSPHATE) LOTION CLEOCIN T (CLINDAMYCIN PHOSPHATE) GEL [PHARMACIA AND UPJOHN COMPANY]	13
ALLANTOIN	INACTIVE INGREDIENT	344S277G0Z	CLEOCIN T (CLINDAMYCIN PHOSPHATE) SOLUTION CLEOCIN T (CLINDAMYCIN PHOSPHATE) LOTION CLEOCIN T (CLINDAMYCIN PHOSPHATE) GEL [PHARMACIA AND UPJOHN COMPANY]	13
CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED)	INACTIVE INGREDIENT	HHT01ZNK31	CLEOCIN T (CLINDAMYCIN PHOSPHATE) SOLUTION CLEOCIN T (CLINDAMYCIN PHOSPHATE) LOTION CLEOCIN T (CLINDAMYCIN PHOSPHATE) GEL [PHARMACIA AND UPJOHN COMPANY]	13
CETOSTEARYL ALCOHOL	INACTIVE INGREDIENT	2DMT128M1S	CLEOCIN T (CLINDAMYCIN PHOSPHATE) SOLUTION CLEOCIN T (CLINDAMYCIN PHOSPHATE) LOTION CLEOCIN T (CLINDAMYCIN PHOSPHATE) GEL [PHARMACIA AND UPJOHN COMPANY]	13
GLYCERIN	INACTIVE INGREDIENT	PDC6A3C0OX	CLEOCIN T (CLINDAMYCIN PHOSPHATE) SOLUTION CLEOCIN T (CLINDAMYCIN PHOSPHATE) LOTION CLEOCIN T (CLINDAMYCIN PHOSPHATE) GEL [PHARMACIA AND UPJOHN COMPANY]	13
ISOPROPYL ALCOHOL	INACTIVE INGREDIENT	ND2M416302	CLEOCIN T (CLINDAMYCIN PHOSPHATE) SOLUTION CLEOCIN T (CLINDAMYCIN PHOSPHATE) LOTION CLEOCIN T (CLINDAMYCIN PHOSPHATE) GEL [PHARMACIA AND UPJOHN COMPANY]	13
ISOSTEARYL ALCOHOL	INACTIVE INGREDIENT	Q613OCQ44Y	CLEOCIN T (CLINDAMYCIN PHOSPHATE) SOLUTION CLEOCIN T (CLINDAMYCIN PHOSPHATE) LOTION CLEOCIN T (CLINDAMYCIN PHOSPHATE) GEL [PHARMACIA AND UPJOHN COMPANY]	13
METHYLPARABEN	INACTIVE INGREDIENT	A2I8C7HI9T	CLEOCIN T (CLINDAMYCIN PHOSPHATE) SOLUTION CLEOCIN T (CLINDAMYCIN PHOSPHATE) LOTION CLEOCIN T (CLINDAMYCIN PHOSPHATE) GEL [PHARMACIA AND UPJOHN COMPANY]	13
POLYETHYLENE GLYCOL 400	INACTIVE INGREDIENT	B697894SGQ	CLEOCIN T (CLINDAMYCIN PHOSPHATE) SOLUTION CLEOCIN T (CLINDAMYCIN PHOSPHATE) LOTION CLEOCIN T (CLINDAMYCIN PHOSPHATE) GEL [PHARMACIA AND UPJOHN COMPANY]	13
PROPYLENE GLYCOL	INACTIVE INGREDIENT	6DC9Q167V3	CLEOCIN T (CLINDAMYCIN PHOSPHATE) SOLUTION CLEOCIN T (CLINDAMYCIN PHOSPHATE) LOTION CLEOCIN T (CLINDAMYCIN PHOSPHATE) GEL [PHARMACIA AND UPJOHN COMPANY]	13
SODIUM HYDROXIDE	INACTIVE INGREDIENT	55X04QC32I	CLEOCIN T (CLINDAMYCIN PHOSPHATE) SOLUTION CLEOCIN T (CLINDAMYCIN PHOSPHATE) LOTION CLEOCIN T (CLINDAMYCIN PHOSPHATE) GEL [PHARMACIA AND UPJOHN COMPANY]	13
SODIUM LAUROYL SARCOSINATE	INACTIVE INGREDIENT	632GS99618	CLEOCIN T (CLINDAMYCIN PHOSPHATE) SOLUTION CLEOCIN T (CLINDAMYCIN PHOSPHATE) LOTION CLEOCIN T (CLINDAMYCIN PHOSPHATE) GEL [PHARMACIA AND UPJOHN COMPANY]	13
STEARIC ACID	INACTIVE INGREDIENT	4ELV7Z65AP	CLEOCIN T (CLINDAMYCIN PHOSPHATE) SOLUTION CLEOCIN T (CLINDAMYCIN PHOSPHATE) LOTION CLEOCIN T (CLINDAMYCIN PHOSPHATE) GEL [PHARMACIA AND UPJOHN COMPANY]	13
WATER	INACTIVE INGREDIENT	059QF0KO0R	CLEOCIN T (CLINDAMYCIN PHOSPHATE) SOLUTION CLEOCIN T (CLINDAMYCIN PHOSPHATE) LOTION CLEOCIN T (CLINDAMYCIN PHOSPHATE) GEL [PHARMACIA AND UPJOHN COMPANY]	13

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
0009-3116	CLEOCIN T (CLINDAMYCIN PHOSPHATE) SOLUTION CLEOCIN T (CLINDAMYCIN PHOSPHATE) LOTION CLEOCIN T (CLINDAMYCIN PHOSPHATE) GEL [PHARMACIA & UPJOHN COMPANY LLC]	29	Legacy NDC, 6 package rows	20230127_4a3901a4-194f-4a15-9c85-3d0982afcf31.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Cleocin T	CLINDAMYCIN PHOSPHATE	Pharmacia & Upjohn Company LLC	4a3901a4-194f-4a15-9c85-3d0982afcf31	2025-11-24	Warnings, Adverse reactions	Exact identifier ndc (product): 0009-3116

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
EH6D7113I8	CLINDAMYCIN PHOSPHATE	24729-96-2	CLINDAMYCIN PHOSPHATE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
804975	Cleocin T 1 % Topical Solution	PSN	4a3901a4-194f-4a15-9c85-3d0982afcf31	30
804978	Cleocin T 1 % Twice-Daily Topical Gel	PSN	4a3901a4-194f-4a15-9c85-3d0982afcf31	30
804973	Cleocin-T 1 % Topical Lotion	PSN	4a3901a4-194f-4a15-9c85-3d0982afcf31	30
197519	clindamycin phosphate 1 % Topical Lotion	PSN	4a3901a4-194f-4a15-9c85-3d0982afcf31	30
309333	clindamycin phosphate 1 % Topical Solution	PSN	4a3901a4-194f-4a15-9c85-3d0982afcf31	30
2676585	clindamycin phosphate 1 % Twice-Daily Topical Gel	PSN	4a3901a4-194f-4a15-9c85-3d0982afcf31	30
804973	clindamycin 10 MG/ML Topical Lotion [Cleocin-T]	SBD	4a3901a4-194f-4a15-9c85-3d0982afcf31	30
804975	clindamycin 10 MG/ML Topical Solution [Cleocin-T]	SBD	4a3901a4-194f-4a15-9c85-3d0982afcf31	30
804978	Twice-Daily clindamycin 0.01 MG/MG Topical Gel [Cleocin-T]	SBD	4a3901a4-194f-4a15-9c85-3d0982afcf31	30
197519	clindamycin 10 MG/ML Topical Lotion	SCD	4a3901a4-194f-4a15-9c85-3d0982afcf31	30
309333	clindamycin 10 MG/ML Topical Solution	SCD	4a3901a4-194f-4a15-9c85-3d0982afcf31	30
2676585	Twice-Daily clindamycin 0.01 MG/MG Topical Gel	SCD	4a3901a4-194f-4a15-9c85-3d0982afcf31	30
804975	Cleocin T Pledget 1 % Topical Solution	SY	4a3901a4-194f-4a15-9c85-3d0982afcf31	30
804978	Cleocin-T (as clindamycin phosphate) 1 % Topical Gel	SY	4a3901a4-194f-4a15-9c85-3d0982afcf31	30
804973	Cleocin-T (as clindamycin phosphate) 1 % Topical Lotion	SY	4a3901a4-194f-4a15-9c85-3d0982afcf31	30
804975	Cleocin-T (as clindamycin phosphate) 1 % Topical Solution	SY	4a3901a4-194f-4a15-9c85-3d0982afcf31	30
804978	Cleocin-T 0.01 MG/MG Topical Gel	SY	4a3901a4-194f-4a15-9c85-3d0982afcf31	30
804973	Cleocin-T 1 % Topical Lotion	SY	4a3901a4-194f-4a15-9c85-3d0982afcf31	30
804975	Cleocin-T 1 % Topical Solution	SY	4a3901a4-194f-4a15-9c85-3d0982afcf31	30
804978	Cleocin-T 1 % Twice-Daily Topical Gel	SY	4a3901a4-194f-4a15-9c85-3d0982afcf31	30
804973	Cleocin-T 10 MG/ML Topical Lotion	SY	4a3901a4-194f-4a15-9c85-3d0982afcf31	30
804975	Cleocin-T 10 MG/ML Topical Solution	SY	4a3901a4-194f-4a15-9c85-3d0982afcf31	30
197519	clindamycin (as clindamycin phosphate) 1 % Topical Lotion	SY	4a3901a4-194f-4a15-9c85-3d0982afcf31	30
309333	clindamycin (as clindamycin phosphate) 1 % Topical Solution	SY	4a3901a4-194f-4a15-9c85-3d0982afcf31	30
2676585	clindamycin (as clindamycin phosphate) 1 % Twice-Daily Topical Gel	SY	4a3901a4-194f-4a15-9c85-3d0982afcf31	30
197519	clindamycin 1 % Topical Lotion	SY	4a3901a4-194f-4a15-9c85-3d0982afcf31	30
309333	clindamycin 1 % Topical Solution	SY	4a3901a4-194f-4a15-9c85-3d0982afcf31	30
804978	Twice-Daily Cleocin-T 0.01 MG/MG Topical Gel	SY	4a3901a4-194f-4a15-9c85-3d0982afcf31	30

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
0009-3116-01	00009311601	1 BOTTLE in 1 CARTON (0009-3116-01) > 30 mL in 1 BOTTLE	1 bottle	1980-06-20	0000-00-00	No	No	Current
0009-3116-02	00009311602	60 mL in 1 BOTTLE	60 ml					Historical
0009-3116-14	00009311614	1 mL in 1 PACKET	1 ml					Historical